Amedisys Inc (AMED): Price and Financial Metrics

Amedisys Inc (AMED): $124.26

4.22 (+3.52%)

POWR Rating

Component Grades














  • AMED scores best on the Quality dimension, with a Quality rank ahead of 96.24% of US stocks.
  • AMED's strongest trending metric is Growth; it's been moving down over the last 179 days.
  • AMED's current lowest rank is in the Momentum metric (where it is better than 17.16% of US stocks).

AMED Stock Summary

  • Amedisys Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 79.02% of US listed stocks.
  • The price/operating cash flow metric for Amedisys Inc is higher than 81.38% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 77.7%, Amedisys Inc's debt growth rate surpasses 87.46% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Amedisys Inc, a group of peers worth examining would be FHB, TTEC, AP, SSB, and AUB.
  • AMED's SEC filings can be seen here. And to visit Amedisys Inc's official web site, go to

AMED Valuation Summary

  • AMED's price/earnings ratio is 24.2; this is 33.7% lower than that of the median Healthcare stock.
  • Over the past 243 months, AMED's price/earnings ratio has gone up 20.4.
  • Over the past 243 months, AMED's price/sales ratio has gone up 2.4.

Below are key valuation metrics over time for AMED.

Stock Date P/S P/B P/E EV/EBIT
AMED 2021-08-31 2.7 6.8 24.2 20.0
AMED 2021-08-30 2.6 6.6 23.3 19.2
AMED 2021-08-27 2.6 6.6 23.4 19.4
AMED 2021-08-26 2.6 6.6 23.2 19.2
AMED 2021-08-25 2.7 6.7 23.6 19.5
AMED 2021-08-24 2.7 6.8 24.1 19.9

AMED Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at 78.1%.
  • Its 4 year net cashflow from operations growth rate is now at 78.1%.
  • The 5 year revenue growth rate now stands at 49.12%.
Over the past 34 months, AMED's revenue has gone up $483,456,000.

The table below shows AMED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 2,214.112 188.893 209.072
2021-09-30 2,205.5 249.639 220.176
2021-06-30 2,196.085 270.955 247.151
2021-03-31 2,116.978 336.919 201.676
2020-12-31 2,071.519 288.952 183.608
2020-09-30 2,021.492 298.26 166.112

AMED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMED has a Quality Grade of A, ranking ahead of 99.52% of graded US stocks.
  • AMED's asset turnover comes in at 1.321 -- ranking 11th of 81 Healthcare stocks.
  • RDNT, CHE, and VCYT are the stocks whose asset turnover ratios are most correlated with AMED.

The table below shows AMED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 1.321 0.446 0.742
2021-06-30 1.385 0.449 0.838
2021-03-31 1.325 0.435 0.601
2020-12-31 1.325 0.428 0.465
2020-09-30 1.359 0.419 0.395
2020-06-30 1.419 0.409 0.355

AMED Price Target

For more insight on analysts targets of AMED, see our AMED price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $240.92 Average Broker Recommendation 1.62 (Moderate Buy)

AMED Stock Price Chart Interactive Chart >

Price chart for AMED

AMED Price/Volume Stats

Current price $124.26 52-week high $276.21
Prev. close $120.04 52-week low $109.53
Day low $121.19 Volume 150,302
Day high $124.94 Avg. volume 326,350
50-day MA $147.32 Dividend yield N/A
200-day MA $157.84 Market Cap 4.05B

Amedisys Inc (AMED) Company Bio

Amedisys provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The company was founded in 1982 and is based in Baton Rouge, Louisiana.

AMED Latest News Stream

Event/Time News Detail
Loading, please wait...

AMED Latest Social Stream

Loading social stream, please wait...

View Full AMED Social Stream

Latest AMED News From Around the Web

Below are the latest news stories about Amedisys Inc that investors may wish to consider to help them evaluate AMED as an investment opportunity.

Amedisys (AMED) Q4 Earnings Top Estimates, Margins Decline

Robust performances by the Home Health and Hospice segments drove Amedisys' (AMED) fourth-quarter top line.

Yahoo | February 24, 2022

Amedisys Non-GAAP EPS of $1.18 in-line, revenue of $559.32M beats by $4.14M

Amedisys press release (NASDAQ:AMED): Q4 Non-GAAP EPS of $1.18 in-line. Revenue of $559.32M (+1.6% Y/Y) beats by $4.14M. For FY2022, the company expects adjusted diluted EPS in the range of $5.23 to $5.45 based on an estimated 33.2M shares outstanding vs. consensus of $5.84....

Seeking Alpha | February 23, 2022

Amedisys (AMED) Beats Q4 Earnings and Revenue Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 0.86% and 0.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Amedisys Reports Fourth Quarter and Year End 2021 Financial Results; Issues 2022 Guidance

BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2021. Three-Month Periods Ended December 31, 2021 and 2020 Net service revenue increased $8.6 million to $559.3 million compared to $550.7 million in 2020.Net income attributable to Amedisys, Inc. of $34.0 million compared to $45.2 million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $1.04 compared

Yahoo | February 23, 2022

Virginia Mason Franciscan Health Collaborates with Contessa to Bring Hospital-Level Care into Patients' Homes

Virginia Mason Franciscan Health announced a new collaboration with Contessa, an Amedisys company (NASDAQ: AMED), to operate Home Recovery Care. Home Recovery Care brings all the essential elements of hospital care into the comfort and convenience of patients' homes, offering a safe and effective alternative to the traditional inpatient stay. The service will expand access to high-acuity care, increase crucial inpatient capacity and reduce the overall cost of care.

Yahoo | February 23, 2022

Read More 'AMED' Stories Here

AMED Price Returns

1-mo N/A
3-mo -17.34%
6-mo -27.81%
1-year -50.55%
3-year 14.69%
5-year 111.90%
YTD -23.24%
2021 -44.81%
2020 75.73%
2019 42.53%
2018 122.18%
2017 23.65%

Continue Researching AMED

Here are a few links from around the web to help you further your research on Amedisys Inc's stock as an investment opportunity:

Amedisys Inc (AMED) Stock Price | Nasdaq
Amedisys Inc (AMED) Stock Quote, History and News - Yahoo Finance
Amedisys Inc (AMED) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.784 seconds.